Treatment for inflammatory bowel disease
AssigneeSanofi
InventorsAnne MINNICH, Eszter BEKASI, Yong Mi CHOI-SLEDESKI
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for the treatment of an inflammatory bowel disease by the administration of the compound [4-(5-aminomethyl-2-fluorophenyl)piperidine-1-yl][7-fluoro-1-(2-methoxyethyl)-4-trifluoromethoxy-1H-indol-3-yl]methanone, which may be represented as Formula I: or a corresponding N-oxide, prodrug, pharmaceutically acceptable salt or solvate thereof.
Claims4
A method of treating inflammatory bowel disease, comprising:
- administering to a patient in need thereof an effective amount of a compound of Formula I:
- or a corresponding N-oxide, prodrug or pharmaceutically acceptable salt or solvate thereof.
A pharmaceutical composition for treating inflammatory bowel disease, comprising a compound of formula I, or a corresponding N-oxide, prodrug or pharmaceutically acceptable salt or solvate thereof, in combination with a pharmaceutically acceptable excipient.
A method for the treatment of a human or non-human animal patient suffering from, or subject to, a condition that can be ameliorated by the administration of a pharmaceutically effective amount of a compound of Formula I, or a corresponding N-oxide, prodrug or a pharmaceutically acceptable salt or solvate thereof:
- wherein the condition is selected from Crohn's disease and ulcerative colitis.
Dependencies are inferred from the claim text.